Health Condition 1: I10- Essential (primary) hypertension Health Condition 2: I119- Hypertensive heart disease withoutheart failure Health Condition 3: I15- Secondary hypertension
Conditions
Interventions
Intervention1: II.Reduced-sodium, added-potassium salt substitute (85% sodium chloride/ 15 % potassium chloride blend).: The sodium reduction intervention is based upon the provision of reduced-sodium
Sponsors
Resolve to Save Lives
Eligibility
Inclusion criteria
Inclusion criteria: -Male or female aged 18 years or over. -History of hypertension diagnosed by health professionalâ??antihypertensive drugs may or may not be used for management. - Eat most of their meals in/from the home i.e., at least 2 major meals are cooked from home for at least 25 days a month. - Consent to participate.
Exclusion criteria
Exclusion criteria: - They or any other household members are using a potassium-sparing diuretic, but not if they use other hypertensive medications. - They or any other household members used potassium supplements, had any known acute or chronic kidney diseases, - Households having children under 5 years of age, pregnant or lactating women (owing to data gap on safety in children) - They have any other reason for concern about use of salt substitute, - Subjects who are not expected to stay in that area for 12 months from the date of initiation of the trial. - Subjects who are already using LSSS salt.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The mean change in systolic and diastolic blood pressures among Intervention Group â??I (enrolled subject and household members) at monthly intervals (1 to 6 months; and at 12 months) from baseline as compared to the control arm and 15% arm will be calculated.Timepoint: Monthly intervals i.e., from 1 to 6 months; and at 12 months from baseline as compared to the control arm and 15% arm will be calculated. | — |
Secondary
| Measure | Time frame |
|---|---|
| The mean change in systolic and diastolic blood pressures among Intervention Group â??II 15% arm (enrolled subject and household members) at monthly intervals (1 to 6 months; and at 12 months) from baseline as compared to the control arm will be calculated.Timepoint: Monthly intervals i.e., from 1 to 6 months; and at 12 months from baseline as compared to the control arm will be calculated. | — |
Countries
India
Contacts
Public ContactDr C S Surya Goud
ICMR-NATIONAL INSTITUTE OF NUTRITION
Outcome results
None listed